SS Innovations International, Inc. (Nasdaq: SSII) announced the successful completion of a landmark long-distance cross-border telesurgery, performed on May 2, 2026, during the Royal Australian College of Surgeons Annual Scientific Congress. The procedure, a robotic gastrojejunostomy, was conducted by Dr. Mohit Bhandari, President of IRCAD India, who operated from Perth, Australia, while the patient was located in Indore, India—a distance of over 4,500 miles.
The telesurgery utilized the company's SSi Mantra surgical robotic system and the SSi MantrAsana tele-surgeon console, a compact, chair-based variant of the standard surgeon command center. This portable console enables surgeons to perform procedures from various locations, including physician offices, through ultra-low latency connectivity, high-definition visualization, and precise instrument control. According to the company, more than 170 telesurgeries, including intricate cardiac procedures, have been performed with the SSi Mantra system to date.
Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, stated, 'We thank the Royal Australian College of Surgeons for this opportunity to demonstrate the advanced telesurgery capabilities of our SSi Mantra surgical robotic system. We believe that telesurgery has the power to transform traditional healthcare delivery and democratize access to global surgical expertise.'
The successful demonstration highlights the potential of telesurgery to bridge geographical gaps, allowing patients in remote or underserved regions to access specialized surgical care from world-class surgeons. This technology could significantly impact global healthcare by reducing the need for patient travel, lowering costs, and improving outcomes through timely interventions. For the industry, it showcases the viability of robotic telesurgery as a standard practice, potentially accelerating adoption of similar systems worldwide.
SS Innovations, headquartered in India and listed on the Nasdaq, aims to make robotic surgery affordable and accessible globally. The SSi Mantra system features 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, and over 40 types of robotic endo-surgical instruments. It has been clinically validated in India across more than 100 different surgical procedures. The company plans to expand its global presence with its cost-effective solutions. More information is available on the company's website at ssinnovations.com.
This achievement not only underscores SS Innovations' technological leadership but also points to a future where surgical expertise knows no borders, potentially leveling the playing field for healthcare access across continents.
